Short QT Syndrome and Hydroquinidine: Rare Diseases and Unavailable Drugs.

@article{Brugada2017ShortQS,
  title={Short QT Syndrome and Hydroquinidine: Rare Diseases and Unavailable Drugs.},
  author={Pedro Brugada},
  journal={Journal of the American College of Cardiology},
  year={2017},
  volume={70 24},
  pages={
          3016-3017
        }
}
I n this issue of the Journal, Mazzanti et al. (1) report the therapeutic effects of hydroquinidine (HQ) in a small series of patients with the rare inherited arrhythmia known as short QT syndrome (SQTS) (2). Because of the rarity of the disease, the number of patients included in this study is necessarily limited. The study lacks a control series receiving placebo. No mention is made of the previous study by Gaita et al. (3) on the effects of HQ on SQTS, also in a small series of patients. The… CONTINUE READING

Topics from this paper.

References

Publications referenced by this paper.